{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:28:14Z","timestamp":1775176094298,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13104-018-3404-8","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T08:53:52Z","timestamp":1526892832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Unintentional sulfonylurea toxicity due to a drug\u2013drug interaction: a case report"],"prefix":"10.1186","volume":"11","author":[{"given":"Keith","family":"Gunaratne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"key":"3404_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1067\/mem.2001.114314","volume":"38","author":"RA Harrigan","year":"2001","unstructured":"Harrigan RA, Nathan MS, Beattie P. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Ann Emerg Med. 2001;38:68\u201378.","journal-title":"Ann Emerg Med"},{"key":"3404_CR2","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1517\/17425255.2012.722619","volume":"8","author":"A Holstein","year":"2012","unstructured":"Holstein A, Beil W, Kovacs P. CYP2C metabolism of oral antidiabetic drugs-impact on pharmacokinetics, drug interactions and pharmacogenetic aspects. Expert Opin Drug Metab Toxicol. 2012;8:1549\u201363.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3404_CR3","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/ctr.12834","volume":"30","author":"MT Levine","year":"2016","unstructured":"Levine MT, Chandrasekar PH. Adverse effects of voriconazole: over a decade of use. Clin Transplant. 2016;30:1377\u201386.","journal-title":"Clin Transplant"},{"key":"3404_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3109\/15563650.2012.734626","volume":"50","author":"M Glatstein","year":"2012","unstructured":"Glatstein M, Scolnik D, Bentur Y. Octreotide for the treatment of sulfonylurea poisoning. Clin Toxicol. 2012;50:795\u2013804.","journal-title":"Clin Toxicol"},{"key":"3404_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1365-2796.2010.02257.x","volume":"268","author":"T Tirkkonen","year":"2010","unstructured":"Tirkkonen T, Heikkil\u00e4 P, Huupponen R, Laine K. Potential CYP2C9-mediated drug\u2013drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide. J Intern Med. 2010;268:359\u201366.","journal-title":"J Intern Med"},{"key":"3404_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/2042018816638050","volume":"7","author":"M May","year":"2016","unstructured":"May M, Schindler C. Clinically and pharmacologically relevant interactions of antidiabetic drugs. Ther Adv Endocrinol Metab. 2016;7:69\u201383.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"3404_CR7","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1001\/jama.289.13.1652","volume":"289","author":"DN Juurlink","year":"2003","unstructured":"Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug\u2013drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289:1652.","journal-title":"JAMA"},{"key":"3404_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/bcp.12822","volume":"81","author":"W Klein-Schwartz","year":"2016","unstructured":"Klein-Schwartz W, Stassinos GL, Isbister GK. Treatment of sulfonylurea and insulin overdose. Br J Clin Pharmacol. 2016;81:496\u2013504.","journal-title":"Br J Clin Pharmacol"},{"key":"3404_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1067\/mem.2000.108183","volume":"36","author":"SA McLaughlin","year":"2000","unstructured":"McLaughlin SA, Crandall CS, McKinney PE, Litovitz T, Klein-Schwartz W, Dyer K, et al. Octreotide: an antidote for sulfonylurea-induced hypoglycemia. Ann Emerg Med. 2000;36:133\u20138.","journal-title":"Ann Emerg Med"},{"key":"3404_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.annemergmed.2007.11.043","volume":"51","author":"M Francis","year":"2008","unstructured":"Francis M, Langhan T, Prosser J, Hoffman R, Fasano CJ, O\u2019Malley G, et al. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia. Ann Emerg Med. 2008;51:795\u20136.","journal-title":"Ann Emerg Med"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-3404-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-018-3404-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-3404-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T19:06:21Z","timestamp":1558379181000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-018-3404-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3404"],"URL":"https:\/\/doi.org\/10.1186\/s13104-018-3404-8","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]},"assertion":[{"value":"18 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"331"}}